2.26
+0.03(+1.35%)
Currency In CHF
Address
Avenue de Secheron 15
Geneva, 1202
Switzerland
Phone
N/A
Sector
Industrials
Industry
Specialty Business Services
Employees
31
First IPO Date
January 18, 2021
| Name | Title | Pay | Year Born |
| Paolo Galfetti | Chief Business Officer | 526,057 | 1965 |
| Giorgio Reiner | Chief Scientific Officer | 0 | 1965 |
| Jeremy Meinen | Chief Financial Officer | 0 | 1989 |
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.